Tokyo Tape
Sign in
← Carna Biosciences

Quarterly report · Q3

4572.TEDINET S100PEWN
Period2022-01-01 → 2022-09-30
Filed2022-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥1.1bn2022-01-01 → 2022-09-30Cons.Net sales
Revenue¥2.0bn2021-01-01 → 2021-12-31Cons.Net sales (5-year summary)
Revenue¥637m2021-01-01 → 2021-09-30Cons.Net sales
Operating income−¥754m2022-01-01 → 2022-09-30Cons.Operating income
Operating income−¥1.2bn2021-01-01 → 2021-09-30Cons.Operating income
Ordinary income−¥736m2022-01-01 → 2022-09-30Cons.Ordinary income
Ordinary income−¥523m2021-01-01 → 2021-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥1.2bn2021-01-01 → 2021-09-30Cons.Ordinary income
Profit before tax−¥779m2022-01-01 → 2022-09-30Cons.Income before income taxes
Profit before tax−¥1.2bn2021-01-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)−¥795m2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥534m2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥1.2bn2021-01-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income−¥795m2022-01-01 → 2022-09-30Cons.Profit loss
Net income−¥1.2bn2021-01-01 → 2021-09-30Cons.Profit loss
Total assets¥4.5bnat 2022-09-30Cons.Assets
Total assets¥5.4bnat 2021-12-31Cons.Assets
Total assets¥4.2bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥604mat 2022-09-30Cons.Liabilities
Total liabilities¥1.1bnat 2021-12-31Cons.Liabilities
Net assets / equity¥3.9bnat 2022-09-30Cons.Net assets
Net assets / equity¥4.3bnat 2021-12-31Cons.Net assets
Net assets / equity¥3.5bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥3.7bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥3.8bnat 2021-12-31Cons.Cash and deposits
EPS (basic)¥-58.562022-01-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-31.922022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-42.12021-01-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-94.242021-01-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-31.682021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio86.5%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio79.3%at 2021-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio82.4%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
jpcrp040300-q3r_E00987-000Drug Discovery Businessreportable segmentrevenue2022-01-01 → 2022-09-30¥286m
jpcrp040300-q3r_E00987-000Drug Discovery Businessreportable segmentrevenue external2022-01-01 → 2022-09-30¥286m
jpcrp040300-q3r_E00987-000Drug Discovery Businessreportable segmentsegment profit2022-01-01 → 2022-09-30−¥1.1bn
jpcrp040300-q3r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2022-01-01 → 2022-09-30¥810m
jpcrp040300-q3r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2022-01-01 → 2022-09-30¥810m
jpcrp040300-q3r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2022-01-01 → 2022-09-30¥336m
jpcrp040300-q3r_E00987-000Drug Discovery Businessreportable segmentsegment profit2021-01-01 → 2021-09-30−¥1.4bn
jpcrp040300-q3r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2021-01-01 → 2021-09-30¥637m
jpcrp040300-q3r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2021-01-01 → 2021-09-30¥637m
jpcrp040300-q3r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2021-01-01 → 2021-09-30¥199m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 315
ItemContextValueUnit
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member7100
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0005
Number of shares held in own name treasury shares etcCurrentQuarterInstant7100
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant7100
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0005
Cash and depositsPrior1YearInstant3817834000JPY
Cash and depositsCurrentQuarterInstant3727485000JPY
Accounts receivable tradePrior1YearInstant1243839000JPY
Accounts receivable tradeCurrentQuarterInstant108462000JPY
Merchandise and finished goodsPrior1YearInstant72514000JPY
Merchandise and finished goodsCurrentQuarterInstant81414000JPY
Work in processPrior1YearInstant7521000JPY
Work in processCurrentQuarterInstant6739000JPY
Raw materials and suppliesPrior1YearInstant30453000JPY
Raw materials and suppliesCurrentQuarterInstant28517000JPY
Other caPrior1YearInstant146324000JPY
Other caCurrentQuarterInstant414550000JPY
Current assetsPrior1YearInstant5318487000JPY
Current assetsCurrentQuarterInstant4367170000JPY
Property plant and equipmentPrior1YearInstant51574000JPY
Property plant and equipmentCurrentQuarterInstant110988000JPY
Intangible assetsPrior1YearInstant2738000JPY
Intangible assetsCurrentQuarterInstant2120000JPY
Investments and other assetsPrior1YearInstant59760000JPY
Investments and other assetsCurrentQuarterInstant67459000JPY
Noncurrent assetsPrior1YearInstant114073000JPY
Noncurrent assetsCurrentQuarterInstant180568000JPY
AssetsPrior1YearInstant5432560000JPY
AssetsCurrentQuarterInstant4547738000JPY
Accounts payable tradePrior1YearInstant2294000JPY
Accounts payable tradeCurrentQuarterInstant3241000JPY
Current portion of bondsPrior1YearInstant28000000JPY
Current portion of bondsCurrentQuarterInstant32000000JPY
Current portion of long term loans payablePrior1YearInstant211497000JPY
Current portion of long term loans payableCurrentQuarterInstant121458000JPY
Accounts payable otherPrior1YearInstant307832000JPY
Accounts payable otherCurrentQuarterInstant179837000JPY
Income taxes payablePrior1YearInstant24236000JPY
Income taxes payableCurrentQuarterInstant17527000JPY
Other clPrior1YearInstant200794000JPY
Other clCurrentQuarterInstant16139000JPY
Current liabilitiesPrior1YearInstant774655000JPY
Current liabilitiesCurrentQuarterInstant370203000JPY
Bonds payablePrior1YearInstant32000000JPY
Bonds payableCurrentQuarterInstant－JPY
Long term loans payablePrior1YearInstant268390000JPY
Long term loans payableCurrentQuarterInstant178399000JPY
Asset retirement obligations nclPrior1YearInstant37434000JPY
Asset retirement obligations nclCurrentQuarterInstant37888000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass